Joan Roig Soriano

Institutions of which they are part

Main researcher
Gene Therapy at Nervous System

Vall Hebron Institut de Recerca

Joan Roig Soriano

Institutions of which they are part

Main researcher
Gene Therapy at Nervous System

Vall Hebron Institut de Recerca

Projects

Bringing Klotho protein as a new therapy against age-associated muscle degeneration

IP: Joan Roig Soriano
Collaborators: Miguel Chillon Rodriguez, Elsa Ibarrola Carrasco, David Ramirez Gomez
Funding agency: Fundació Institut de Recerca HUVH
Funding: 10000
Reference: VHIR-FIT-24-002
Duration: 13/12/2024 - 12/12/2025

Towards an effective and safe therapy for hormonal-deficiency osteoporosis based on klotho protein

IP: Joan Roig Soriano
Collaborators: Miguel Chillon Rodriguez
Funding agency: Fundació "La Caixa"
Funding: 64450
Reference: CI24-20581
Duration: 15/10/2024 - 14/10/2026

Related news

European Partnership Opens a New Era in Rare Disease Research

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

VHIR leads a gene therapy study to stop the progression of neurodegenerative diseases

This gene therapy protects mice against cognitive deficits associated with aging, improves motor function, and delays the onset of diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease.

Vall d'Hebron trains future professionals in the use of gene therapy

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.